[1] |
DENG S H, WU D M, LI L, et al. TBHQ attenuates ferroptosis against 5-fluorouracil-induced intestinal epithelial cell injury and intestinal mucositis via activation of Nrf2[J]. Cellular & Molecular Biology Letters, 2021, 26(1): 48. |
|
[2] |
LONGLEY D B, HARKIN D P, JOHNSTON P G. 5-Fluorouracil: mechanisms of action and clinical strategies[J]. Nature Reviews Cancer, 2003, 3(5): 330-338. DOI:10.1038/nrc1074 |
|
[3] |
ZHANG L, JIN Y Y, PENG J, et al. Qingjie Fuzheng Granule attenuates 5-fluorouracil-induced intestinal mucosal damage[J]. Biomedecine & Pharmacotherapie, 2019, 118: 109223. |
|
[4] |
MCQUADE R M, STOJANOVSKA V, DONALD E, et al. Gastrointestinal dysfunction and enteric neurotoxicity following treatment with anticancer chemotherapeutic agent 5-fluorouracil[J]. Neurogastroenterology and Motility, 2016, 28(12): 1861-1875. DOI:10.1111/nmo.12890 |
|
[5] |
王霖, 王睿, 魏广义, 等. 隐丹参酮改善小鼠化疗性肠黏膜炎的作用及机制研究[J]. 药学学报, 2020, 55(8): 1801-1811. WANG L, WANG R, WEI G Y, et al. Study on the therapeutic effects and mechanism of cryptotanshinone on mice with chemotherapy-induced mucositis[J]. Acta Pharmaceutica Sinica, 2020, 55(8): 1801-1811. DOI:10.16438/j.0513-4870.2019-1023 |
|
[6] |
LU D X, LIU F, WU H, et al. Wumei Pills attenuates 5-fluorouracilinduced intestinal mucositis through Toll-like receptor 4/myeloid differentiation factor 88/nuclear factor-κB pathway and microbiota regulation[J]. World Journal of Gastroenterology, 2022, 28(32): 4574-4599. DOI:10.3748/wjg.v28.i32.4574 |
|
[7] |
李焕, 贾妮. 论生脉散研究进展[J]. 辽宁中医药大学学报, 2020, 22(10): 190-193. LI H, JIA N. Research progress of Shengmai Powder[J]. Journal of Liaoning University of Traditional Chinese Medicine, 2020, 22(10): 190-193. DOI:10.13194/j.issn.1673-842x.2020.10.045 |
|
[8] |
鞠爱春, 崔子悦, 王蕴华, 等. 生脉方类注射剂抗肿瘤药理及临床研究进展[J]. 药物评价研究, 2021, 44(11): 2289-2299. JU A C, CUI Z Y, WANG Y H, et al. Research progress of antitumor effects of Shengmai prescription injection[J]. Drug Evaluation Research, 2021, 44(11): 2289-2299. |
|
[9] |
朱荣飞. 生脉注射液联合FOLFOX化疗方案治疗结直肠癌的临床效果观察[J]. 临床医药文献电子杂志, 2018, 5(73): 111-112. ZHU R F. Clinical observation of Shengmai injection combined with FOLFOX chemotherapy in the treatment of colorectal cancer[J]. Journal of Clinical Medical Literature, 2018, 5(73): 111-112. DOI:10.3877/j.issn.2095-8242.2018.73.076 |
|
[10] |
易琰斐, 何怀阳. 生脉散加味对晚期肺腺癌化疗毒副反应及临床症状、生活质量的影响分析[J]. 现代诊断与治疗, 2020, 31(2): 183-185. YI Y F, HE H Y. Analysis of the influence of modified Shengmai Powder on the side effects, clinical symptoms and quality of life of chemotherapy for advanced lung adenocarcinoma[J]. Modern Diagnosis and Treatment, 2020, 31(2): 183-185. |
|
[11] |
ZHANG S, LIU Y N, XIANG D C, et al. Assessment of doseresponse relationship of 5-fluorouracil to murine intestinal injury[J]. Biomedecine & Pharmacotherapie, 2018, 106: 910-916. |
|
[12] |
YIM S K, KIM S W, LEE S T. Efficient stool collection methods for evaluating the diarrhea score in mouse diarrhea models[J]. In Vivo, 2021, 35(4): 2115-2125. DOI:10.21873/invivo.12481 |
|
[13] |
肖霞芳, 魏开建. 中医药防治中晚期结肠癌化疗副作用研究进展[J]. 亚太传统医药, 2017, 13(12): 72-75. XIAO X F, WEI K J. Research progress on chemotherapy side effects of traditional Chinese medicine in the prevention and treatment of advanced colon cancer[J]. Asia-Pacific Traditional Medicine, 2017, 13(12): 72-75. |
|
[14] |
赵若含, 李慧杰, 李秀荣. 中医药防治化疗后胃肠道反应的概况[J]. 中国中西医结合消化杂志, 2021, 29(10): 749-752. ZHAO R H, LI H J, LI X R. Overview of traditional Chinese medicine in prevention and treatment of gastrointestinal reactions after chemotherapy[J]. Chinese Journal of Integrated Traditional and Western Medicine on Digestion, 2021, 29(10): 749-752. DOI:10.3969/j.issn.1671-038X.2021.10.15 |
|
[15] |
姜彧, 孙磊涛, 严雯婷, 等. 中药方剂防治化疗消化道不良反应的研究进展[J]. 中华中医药杂志, 2022, 37(11): 6305-6308. JIANG Y, SUN L T, YAN W T, et al. Research progress on prevention and treatment of gastrointestinal adverse reactions of chemotherapy with Chinese medicine prescriptions[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2022, 37(11): 6305-6308. |
|
[16] |
HAMOUDA N, SANO T, OIKAWA Y, et al. Apoptosis, dysbiosis and expression of inflammatory cytokines are sequential events in the development of 5-fluorouracil-induced intestinal mucositis in mice[J]. Basic & Clinical Pharmacology & Toxicology, 2017, 121(3): 159-168. |
|
[17] |
胡少博, 于然, 娄彦妮, 等. 基于关联规则和因子分析挖掘中医治疗恶性肿瘤放化疗性口腔黏膜炎用药规律[J]. 北京中医药, 2021, 40(1): 58-62. HU S B, YU R, LOU Y N, et al. Study on regulations of drug-use of traditional Chinese medicine used for oral mucositis caused by radiotherapy and chemotherapy based on association rules and factor analysis[J]. Beijing Journal of Traditional Chinese Medicine, 2021, 40(1): 58-62. |
|
[18] |
周卫东, 项磊, 陈泽伟, 等. 五味子多糖对化疗性肠道黏膜炎小鼠的保护作用[J]. 中国实验方剂学杂志, 2016, 22(22): 124-128. ZHOU W D, XIANG L, CHEN Z W, et al. Schisandrae Chinensis fructus polysaccharide protects against chemotherapy-induced enteritis in mice models[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2016, 22(22): 124-128. |
|
[19] |
DONG J Y, LIANG W, WANG T X, et al. Saponins regulate intestinal inflammation in colon cancer and IBD[J]. Pharmacological Research, 2019, 144: 66-72. |
|
[20] |
PATNAUDE L, MAYO M, MARIO R, et al. Mechanisms and regulation of IL-22-mediated intestinal epithelial homeostasis and repair[J]. Life Sciences, 2021, 271: 119195. |
|
[21] |
陆宁, 刘慧, 徐央波, 等. 健脾清肠法通过调控TLRs/NF-κB通路抑制化疗致肠黏膜炎作用的机制探究[J]. 中华中医药学刊, 2022, 40(7): 47-50, 261. LU N, LIU H, XU Y B, et al. Mechanism of invigorating spleen and clearing intestines method inhibiting chemotherapy-induced intestinal mucositis by regulating TLRs/NF-κB pathway[J]. Chinese Archives of Traditional Chinese Medicine, 2022, 40(7): 47-50, 261. |
|
[22] |
侯玥, 宫平, 杨羽, 等. 血清二胺氧化酶测定的临床应用进展[J]. 中国实验诊断学, 2015, 19(11): 1985-1987. HOU Y, GONG P, YANG Y, et al. Progress in clinical application of serum diamine oxidase determination[J]. Chinese Journal of Laboratory Diagnosis, 2015, 19(11): 1985-1987. |
|
[23] |
JI J J, GU Z T, LI H, et al. Cryptdin-2 predicts intestinal injury during heatstroke in mice[J]. International Journal of Molecular Medicine, 2018, 41(1): 137-146. |
|
[24] |
ZHUANG S, ZHONG J, BIAN Y F, et al. Rhein ameliorates lipopolysaccharide-induced intestinal barrier injury via modulation of Nrf2 and MAPKs[J]. Life Sciences, 2019, 216: 168-175. |
|
[25] |
SONIS S T. The pathobiology of mucositis[J]. Nature Reviews Cancer, 2004, 4(4): 277-284. |
|
[26] |
ALI J, KHAN A U, SHAH F A, et al. Mucoprotective effects of Saikosaponin-a in 5-fluorouracil-induced intestinal mucositis in mice model[J]. Life Sciences, 2019, 239: 116888. |
|
[27] |
NYSTRÖM E E L, MARTINEZ-ABAD B, ARIKE L, et al. An intercrypt subpopulation of goblet cells is essential for colonic mucus barrier function[J]. Science, 2021, 372(6539): eabb1590. |
|